Clinical Trials Logo

Filter by:
NCT ID: NCT02985957 Active, not recruiting - Prostate Cancer Clinical Trials

A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

CheckMate 650
Start date: March 26, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate cancer (mCRPC).

NCT ID: NCT02985879 Terminated - Clinical trials for Progressive Supranuclear Palsy

A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)

Start date: December 12, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study was to assess efficacy, safety, tolerability, and pharmacokinetics of ABBV-8E12 in participants with progressive supranuclear palsy (PSP).

NCT ID: NCT02984748 Completed - Hearing Loss Clinical Trials

Outcome Prediction in Cochlear Implant Recipients

Start date: October 7, 2014
Phase:
Study type: Observational

The ability to predict post-operative outcomes after implantation is important for a number of reasons, including being able to advise candidates of appropriate expectations using evidence based guidance. The approved study involves investigation of the ability to predict outcomes in the implanted ear alone and in the best-aided binaural listening conditions, examining a number of measured factors both pre-, peri- and post-operatively. The study incorporates a range of functional outcome measures through questionnaires to ascertain social, functional and demographic factors that may be predictive of outcomes. Questionnaires are also administered to determine the degree of benefit obtained after implantation for each individual, since this forms a key component of providing pre-operative counselling to candidates.

NCT ID: NCT02984566 Active, not recruiting - Liver Cancer Clinical Trials

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

TROG1703 LARK
Start date: January 14, 2020
Phase: N/A
Study type: Interventional

Primary and secondary liver cancer patients will receive liver SABR with or without KIM intervention.

NCT ID: NCT02983292 Active, not recruiting - Arthritis Clinical Trials

PyroTITAN Humeral Resurfacing Arthroplasty (HRA)

HRA
Start date: October 2016
Phase:
Study type: Observational

The study is designed as a single center, post-market, non-randomized, open-label, observational clinical study with retrospective and prospective enrollment to evaluate the 2-year post implantation survivorship of the PyroTITAN™ HRA device following the implementation of a new proof test to identify and eliminate devices with sub-standard mechanical integrity.

NCT ID: NCT02981472 Completed - Thrombosis Clinical Trials

A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Start date: January 19, 2017
Phase: Phase 2
Study type: Interventional

To investigate the safety and pharmacokinetics of apixaban in children with congenital or acquired heart disease who have a need for anticoagulation.

NCT ID: NCT02981407 Completed - Clinical trials for Myocardial Infarction

Myocardial Ischemia and Transfusion

MINT
Start date: April 25, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.

NCT ID: NCT02981355 Terminated - Clinical trials for Degenerative Lesion of Articular Cartilage of Knee

Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions

RECORD
Start date: July 26, 2017
Phase: Phase 4
Study type: Interventional

This multi-centre randomized, controlled trial will assess the impact of BST-CarGel scaffold with microfracture versus microfracture alone on short and long term clinical benefit in patients with cartilage lesions of the femoral condyle requiring operative management.

NCT ID: NCT02981342 Completed - Clinical trials for Pancreatic Ductal Adenocarcinoma

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Start date: January 12, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of abemaciclib alone and in combination with other drugs versus standard of care in participants with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC).

NCT ID: NCT02980874 Terminated - Macular Edema Clinical Trials

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

SAPPHIRE
Start date: January 31, 2017
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, randomized, masked, controlled, parallel group study of 12 months duration in treatment naïve subjects with RVO.